“it has been good working with the majority. We cannot agree on this amendment. Even the FDA has asked for this amendment. When they testified before our committee in January, they said the weakness is labeling. "The goal of pediatric exclusivity should be labeling," that is a quote from the FDA. Section 552 does not work in the real world; that is why we need this amendment.”
Discussing the need for an amendment related to pediatric exclusivity and FDA labeling during a committee meeting.
Share
More from Bart Stupak
We need to extend the time because, in all honesty, the Department of Commerce has made many mistakes in this program, and to ensure that all Americans have an opportunity to make the transition and to get their converter boxes, we have to…
I am pleased health care reform passed the House of Representatives and the Congress on March 21 so 32 million more Americans will have access to health insurance. Americans are already realizing the benefits of this legislation. For…
5 minutes is not nearly enough time to do justice to Congressman John Dingell's record-breaking 53 years of service in the U.S. House of Representatives, but I wish to highlight the profound impact his work has had on the lives of…
I urge Members to support the Dingell/Stupak/ Miller amendment to H.R. 5136, the Defense Authorization Act. I wish to thank my colleagues Congressmen Dingell and Miller for their work to bring this amendment to the floor. As Chairman of…